相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of β1-integrin in promoting cell motility and tamoxifen resistance of human breast cancer MCF-7 cells
Song Hu et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2023)
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
Rossella Loria et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells
Fatemeh Valinezhad Sani et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2021)
Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway
Yijie Fu et al.
TRANSLATIONAL ONCOLOGY (2020)
GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells
Tenghua Yu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
Wei-Min Chung et al.
CANCERS (2019)
Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors
Rosa Jahangiri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Yinghua Zhu et al.
NATURE COMMUNICATIONS (2018)
ABCG2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining
Junqing Wang et al.
ONCOTARGET (2017)
Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6
Noritaka Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes
Jun Hu et al.
ONCOTARGET (2017)
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer
Juan M. Cejalvo et al.
CANCER RESEARCH (2017)
An in vitro model for the development of acquired tamoxifen resistance
Gamze Guney Eskiler et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
X Sun et al.
ONCOGENE (2014)
Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)
Rubi Viedma-Rodriguez et al.
ONCOLOGY REPORTS (2014)
In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies
Martina McDermott et al.
FRONTIERS IN ONCOLOGY (2014)
Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways
Li-Juan Wang et al.
ONCOLOGY REPORTS (2013)
GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
Zhiqiang Mo et al.
BREAST CANCER RESEARCH (2013)
Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)
Wendy A. Teft et al.
DRUG METABOLISM AND DISPOSITION (2011)
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
Atanas Ignatov et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX
Fatemeh Mosaffa et al.
INFLAMMATION RESEARCH (2009)
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Helen M. Coley
CANCER TREATMENT REVIEWS (2008)
Adjuvant endocrine treatment of early breast cancer
Per Eystein Lonning
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation
S Hiscox et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells
JM Knowlden et al.
ENDOCRINOLOGY (2003)
Flow cytometric analysis of breast cancer resistance protein expression and function
H Minderman et al.
CYTOMETRY (2002)
分享论文
